Boston Scientific Gets CDSCO Panel Nod for Pivotal Clinical Investigation of MANTIS Clip Dr. Divya Colin1 July 2023 5:00 PM ISTNew Delhi: Boston Scientific has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Sun Pharma launches nationwide initiative, #SecondBirthDate on National Doctor’s Day with Rishabh Pant and Mahima Chaudhry Medical Dialogues Bureau1 July 2023 4:27 PM ISTMumbai: On the occasion of National Doctor’s Day, Sun Pharma, India’s largest pharmaceutical company, unveiled an inspiring initiative, titled...
Lupin gets USD 25 million from AbbVie for novel MALT1 inhibitor program to treat hematological cancers Medical Dialogues Bureau1 July 2023 3:16 PM ISTNew Delhi: Drug major Lupin on Thursday said it has received USD 25 million (around Rs 205 crore) from AbbVie Inc for meeting a key development...
Zydus Lifesciences gets tentative nod from USFDA for Palbociclib tablets Medical Dialogues Bureau1 July 2023 3:14 PM ISTNew Delhi: Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Palbociclib tablets,...
USFDA uncovers fresh faults at Aurobindo Pharma MD Bureau1 July 2023 10:00 AM ISTUS Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest drugmakers as the watchdog continues to...
Fire broke out in solvent reactor at Sahithi Pharma unit, 6 injured Ruchika Sharma30 Jun 2023 3:08 PM ISTHyderabad: At least six people have been injured in a fire at a unit of a privately held pharmaceutical company in the southern Indian state of...
Lupin receives over Rs 205 crore from AbbVie for meeting key product development milestone Ruchika Sharma30 Jun 2023 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue ...
Shilpa Biologicals gets marketing authorization permission for Adalimumab 40 mg/0.4mL injection in prefilled syringe in India Ruchika Sharma30 Jun 2023 12:30 PM ISTKarnataka: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited (SML), has received the Marketing...
US FDA declines to approve Regeneron's higher dose Eylea Ruchika Sharma30 Jun 2023 11:00 AM ISTRegeneron was seeking approval for the drug to treat wet AMD, the leading cause of blindness among the elderly, and two eye diseases that are common...
Merck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU Ruchika Sharma30 Jun 2023 10:00 AM ISTMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union,...
Granules India warns of significant loss of revenue, profitability due to cyber attack Ruchika Sharma29 Jun 2023 3:38 PM ISTThe company said on June 29 that a ransomware group had claimed responsibility for the incident.
Cancer plaintiffs drill down on JnJ support for USD 8.9 billion talc deal Ruchika Sharma29 Jun 2023 2:30 PM ISTNew York: The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in...
